Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

Proceedings of the National Academy of Sciences of the United States of America
Kohjiro UekiC Ronald Kahn

Abstract

Insulin resistance, obesity, diabetes, dyslipidemia, and nonalcoholic fatty liver are components of the metabolic syndrome, a disease complex that is increasing at epidemic rates in westernized countries. Although proinflammatory cytokines have been suggested to contribute to the development of these disorders, the molecular mechanism is poorly understood. Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c. Conversely, inhibition of SOCS-1 and -3 in obese diabetic mice improves insulin sensitivity, normalizes the increased expression of SREBP-1c, and dramatically ameliorates hepatic steatosis and hypertriglyceridemia. In obese animals, increased SOCS proteins enhance SREBP-1c expression by antagonizing STAT3-mediated inhibition of SREBP-1c promoter activity. Thus, SOCS proteins play an important role in pathogenesis of the metabolic syndrome by concordantly modulating insulin signaling and cytokine signaling.

References

Jun 26, 1997·Nature·R StarrD J Hilton
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·M NarazakiT Kishimoto
Oct 30, 1998·Diabetologia·J C Pickup, M A Crook
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·R StarrW S Alexander
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·T NakaT Kishimoto
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·I ShimomuraJ L Goldstein
Apr 5, 2000·The Journal of Biological Chemistry·C S ZongL H Wang
May 17, 2000·The Journal of Clinical Investigation·K UekiT Kadowaki
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H SaitoT Kishimoto
May 24, 2000·The Journal of Biological Chemistry·B EmanuelliE Van Obberghen
Jun 3, 2000·Annual Review of Immunology·H YasukawaA Yoshimura
Jul 21, 2000·The Journal of Clinical Investigation·G I Shulman
Aug 5, 2000·The Journal of Biological Chemistry·M Amemiya-KudoN Yamada
Mar 10, 2001·Cell·B M Spiegelman, J S Flier
Jul 24, 2001·JAMA : the Journal of the American Medical Association·A D PradhanP M Ridker
Jul 27, 2001·Diabetes·G MarchesiniN Melchionda
Feb 19, 2002·Nature Genetics·Matthew N PoySonia M Najjar
Mar 28, 2002·Diabetes·Madeline ButlerBrett P Monia
May 8, 2002·The Journal of Clinical Investigation·Jay D HortonMichael S Brown
Sep 14, 2002·The Journal of Biological Chemistry·Liangyou RuiMorris F White
Dec 28, 2002·Genes & Development·Palle G LaustsenC Ronald Kahn
Dec 18, 2003·The Journal of Clinical Investigation·Stuart P WeisbergAnthony W Ferrante
Dec 18, 2003·The Journal of Clinical Investigation·Haiyan XuHong Chen

❮ Previous
Next ❯

Citations

Feb 7, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Hitoshi Shimano
Jan 23, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Vance B Matthews, Mark A Febbraio
Jul 3, 2010·European Journal of Applied Physiology·Ben B YaspelkisJohn A Hawley
Sep 22, 2006·Journal of Gastroenterology·Masafumi Ono, Toshiji Saibara
Jun 23, 2009·Apoptosis : an International Journal on Programmed Cell Death·Jörn M Schattenberg, Marcus Schuchmann
May 26, 2005·Journal of Hepatology·Geoffrey C Farrell
Sep 10, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A YamashitaF Nishimura
May 30, 2006·Nature Medicine·Mihai G NeteaJos W M van der Meer
Jan 26, 2011·IET Systems Biology·C MoyaJ Hahn
Feb 24, 2009·The Journal of Biological Chemistry·Sushant BhatnagarF Bradley Hillgartner
Jan 5, 2011·Antioxidants & Redox Signaling·Maurizio Parola, Fabio Marra
Feb 15, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kristy L TownsendYu-Hua Tseng
Dec 20, 2007·Current Opinion in Nephrology and Hypertension·Jonas Axelsson, Peter Stenvinkel
Jul 14, 2005·Annual Review of Nutrition·Owen P McGuinness
May 14, 2009·American Journal of Physiology. Endocrinology and Metabolism·Guang YangFahumiya Samad
Jul 24, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Janet D SparksCharles E Sparks
Jun 23, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Sean W P KoppeRichard M Green
Apr 24, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ben B YaspelkisTania Y Figueroa
Jan 10, 2008·Blood Purification·Jonas Axelsson
Apr 4, 2007·The Journal of Clinical Investigation·Mark A Febbraio
Mar 3, 2011·The Journal of Clinical Investigation·Brandon C SosEthan J Weiss
May 19, 2005·Arthritis Research & Therapy·Akihiko YoshimuraToshikatsu Hanada
Feb 25, 2010·Journal of Lipid Research·Takashi YamamotoHitoshi Shimano
May 24, 2012·Endocrinology·Naoto NagataFawaz G Haj
Apr 7, 2010·PLoS Computational Biology·Aleksej ZelezniakKiran Raosaheb Patil
Feb 2, 2008·World Journal of Gastroenterology : WJG·Madhusudana Girija Sanal
Sep 19, 2009·World Journal of Gastroenterology : WJG·Mark W Douglas, Jacob George
Nov 1, 2011·World Journal of Gastroenterology : WJG·Metin Basaranoglu, Gökcen Basaranoglu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.